PATENT CLAIM ANALYSIS

Application Number: 16009303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Claim (Index 3):
The method according to  claim 1 , wherein said disease genetic is selected from the group consisting of: Gorlin syndrome, Down syndrome, Feingold syndrome, Hirschsprung's disease, Von Hippel Lindau syndrome, ataxia telangiectasia, Li-Fraumeni syndrome, Turcot syndrome, familial tumors and Parkinson's disease; said tumor is an adult or pediatric tumor of selected from the group consisting in: neuroblastoma,\n retinoblastoma, medulloblastoma, ependymoma, pheochromocytoma, embryonal carcinoma, germ cell tumour, alveolar rabdomyosarcoma, embryonal rabdomiosarcoma, Wilms tumor, clear cell sarcoma of the kidney, synovial sarcoma, hepatoblastoma, acute lymphoid leukaemia, chronic lymphoid leukaemia, acute lymphoblastic leukaemia, chronic lymphoblastic leukaemia, Burkitt's lymphoma, acute myeloid leukaemia, chronic myeloid leukaemia, acute megakaryoblastic leukaemia, B chronic lymphoid leukaemia, T-cell leukaemia, lymphomas, small cell lung cancer (microcytoma), lung adenocarcinoma, squamous cell lung carcinoma, typical and atypical primary lung cancer, large cell lung carcinoma, large-cell neuroendocrine lung carcinoma, glioblastoma, hepatocarcinoma, basal cell carcinoma, ovarian tumour, breast tumor and colon cancer.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14780043', '14533371', '15882221', '15364050', '15222695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7597433417237598
- 35 USC 102 Novelty (BERT): 0.509568860264983
- Combined Prediction Score: 0.7347258935778821
- Mean Citation Score: 236.347142
- Max Citation Score: 246.64674
- Similarity Product: 167.4023105780411

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test